Group 1 - Guangyang Co., Ltd. has decided to terminate the plan to acquire 100% equity of Ningbo Yinqiu Technology Co., Ltd. and will resume trading on May 30, 2025 [1] - Longjing Environmental Protection plans to invest 75.075 million yuan to acquire 20% equity in Zhejiang Jitai Intelligent Technology Co., Ltd. [1] - Fengmao Co., Ltd. intends to invest up to 1.5 billion yuan to establish an automotive parts production base in Jiaxing [2] Group 2 - JinkoSolar has received a government subsidy of 98 million yuan [2] - Huayuan Real Estate has completed the registration of its name change to "Huayuan Holdings," effective June 5, 2025 [2][3] - Haisen Pharmaceutical's general manager plans to reduce his stake by 0.97% of the company's total shares [4][5] Group 3 - Shandong Highway plans to issue bonds not exceeding 8 billion yuan [6] - Mengguli's shareholders plan to collectively reduce their stake by up to 5% [7] - Yihua Tong has terminated its fuel cell comprehensive testing evaluation center project, originally planned for 220 million yuan [9] Group 4 - Ouma Software is the first candidate for the banking industry association's professional qualification examination service project, with a bid of 39.90 yuan per subject [11] - ST Dehao's subsidiary plans to invest 50 million yuan in an automotive LED packaging project [11] - Shuanglin Co., Ltd. plans to raise no more than 1.5 billion yuan through a private placement [12] Group 5 - Huaci Co., Ltd. plans to raise no more than 700 million yuan for the ASEAN Ceramic Valley project [13] - Aisi Kai intends to sign a procurement framework agreement for ceramic 3D printers, not exceeding 7.5 million yuan [14] - Baolingbao's major shareholder plans to reduce their stake by up to 3% [15] Group 6 - Heng Rui Pharmaceutical's subsidiary has received conditional approval for the launch of a class 1 innovative drug for lung cancer treatment [16][17] - *ST Jinguang is facing delisting due to continuous false reporting in annual reports from 2020 to 2023 [18] - Guangxi Broadcasting plans to swap 100% equity of Guangdian Technology for 51% equity of Jiaoke Group, with both assets valued at 1.411 billion yuan [19][20] Group 7 - ST Ruike's stock will be delisted from risk warnings and will change its name to "Guorui Technology" effective June 3, 2025 [21][22]

编号：2025-006 | | ☑特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活 | □媒体采访 □业绩说明会 | | 动类别 | □新闻发布会 □路演活动 | | | □现场参观 □其他（请文字说明其他活动内容） | | 参与单位名称 | 中国银河证券：王晓磊、翟启迪 | | 及人员姓名 | | | 时间 | 2025 年 5 月 29 日 | | 地点 | 博苑股份会议室 | | 上市公司接待 | 1、董事会秘书：张山岗 | | 人员姓名 | 2、财务总监：孙腾 | | | 3、证券事务代表：杨艳丽 1、公司无机碘化物产品的市场前景？ | | | 答：从下游主要需求领域角度看，无机碘化物产品市场前 | | | 景广阔。 | | | （1）医药领域应用与需求 | | | 随着生活水平提高、人口老龄化加剧及健康意识增强，人 | | 投资者关系活 | 均医疗支出预计将持续增长。在肿瘤、心血管疾病和神经系统 | | 动主要内容介 | 疾病诊断领域（如 和 MRI），X 射线造影剂需求将稳步提升， CT | | 绍 | 推动国内造影剂市场规模扩大。同时，进口替代和产品升级将 | | | ...

Market Overview - The Shanghai Composite Index showed a rare bullish signal with a green candlestick, but it did not meet the criteria for a trend reversal, specifically the volume exceeding 1.5 trillion and a price increase over 1.5% [1] - The overall downtrend has not yet confirmed an end, with a likely support level at 3277 points [1] - A potential reversal opportunity may arise after the holiday, particularly on the Wednesday and Thursday following the holiday [1] Short-term Analysis - The market is currently in a corrective phase, with expectations of five downward movements from the peak of 3417 points [2] - The next day's trading is anticipated to see a high followed by a pullback, with a resistance level at 3377 points and support at 3360 points [2] - The overall strategy remains focused on reducing positions until the fifth downward movement is completed, which may occur after the holiday [2] Sector Performance - The ChiNext Index increased by 1.3%, but the downtrend has not yet halted, with a focus on reducing positions during rebounds [3] - The STAR Market saw a 1.6% increase, but it is not considered a critical candlestick [3] - Key sectors showing movement include computer software, autonomous driving, and chemical pharmaceuticals, with the latter being at a high level already [3] Capital Flow - There was a noticeable inflow of capital into various sectors, including software (3.1 billion), ETF (2.5 billion), consumer electronics (1.7 billion), and automotive parts (1.4 billion) [4] - The sectors experiencing significant outflows included general equipment (0.9 billion) and batteries (0.7 billion) [4] - Despite the index not meeting the reversal signal criteria, some sectors have formed critical candlesticks indicating potential upward movement [4]

尽管市场整体尚未形成明显的板块效应，但今天部分板块已经开始有所表现。例如，半导体、软件、计 算机设备等板块出现上涨，这些板块与市场关注的博弈或谈判事件有一定关联，投资者可以结合事件进 展进行进一步分析和布局。此外，化学制药和生物制药板块表现活跃，医药创新领域依然是市场关注的 焦点。在汽车整车板块中，氢燃料电池相关方向开始崭露头角。与锂电池和混动车相比，氢燃料电池作 为一种新兴技术，正在逐渐受到市场关注。虽然新能源汽车整体销量仍在增长，但环比增幅有所放缓， 这促使市场寻找新的替代技术，氢燃料电池的概念炒作也因此逐渐升温。 （原标题：和讯投顾韩东峰：大盘经过缩量后，端午节有行情？） 经过两天的缩量调整之后，市场成交量重新回到万亿之上，显示出一定的试探性上攻意图。首先，央行 的7天逆回购操作已经连续10个交易日进行，这一举措对市场的稳定作用十分明显。通过逆回购操作， 央行向市场注入流动性，缓解了短期资金面的压力，为市场的稳定和反弹提供了基础支持。同时，今天 盘中券商板块全线收红，虽然涨幅并不显著，但这种表现值得关注。券商板块通常被视为市场的先行指 标，其全面收红可能暗示市场情绪正在逐步改善，甚至可能有提前演绎的动作 ...

作者 | 黄绎达 编辑 | 郑怀舟 在A股市场，鲜有连续熊市超过三年的行业板块，而医药板块是其中的典型。从2021年7月到去年924行情启动之前，该板块经历了连续3年的下行调整， 申万医药生物指数在此期间的跌幅高达54%，板块市值近乎腰斩，众多医药龙头股亦同步陷入估值与业绩的双重回调。 在医药板块持续低迷的周期中，曾经风光无两的医药主题基金（以下简称：医药基金）也褪去了往日的光彩。根据wind统计，受医药板块长期熊市的拖 累，即便有去年924行情的提振，今年医药板块有所反弹，目前存续的600余只医药基金中，截至今年5月28日，大约2/3的基金净值目前还在1以下，最低 者甚至只有0.35。 但是从短期来看，进入2025年后，半数以上的医药基金在今年（截至5月28日）取得了正收益，表现优异者如长城医药产业精选、永赢医药创新智选、华 安医药生物、中银大健康等基金的同期收益在47%~56%区间，同类基金同期排名亦均位于前列，似乎医药基金的春天回来了。 那么，驱动医药基金在今年回暖的核心因素都有哪些？医药基金现在还能买吗？ 01 医药大盘反弹在beta层面支撑医药基金走强 医药基金近年来长期表现相对颓势，在不发生风格漂 ...

Core Viewpoint - Baiyunshan (600332) has received approval from the National Medical Products Administration for the marketing application of Tofacitinib Tosylate, which is primarily used for the first-line treatment of advanced liver cancer, advanced kidney cancer, and locally advanced or metastatic thyroid cancer resistant to radioactive iodine therapy [1] Group 1 - Baiyunshan Chemical Pharmaceutical Factory has invested approximately 3.3655 million yuan in the research and development of Tofacitinib Tosylate [1] - The approval will enhance the variety of anti-tumor products offered by Baiyunshan Chemical Pharmaceutical Factory, thereby improving the company's competitiveness in the anti-tumor market [1]

Market Performance - On May 29, A-shares saw a collective increase in the three major indices, with the Shanghai Composite Index rising by 0.7%, the Shenzhen Component Index increasing by 1.24%, and the ChiNext Index up by 1.37% [1] - The North Stock 50 index experienced a significant rise of 2.73% [1] - The total trading volume in the two markets was approximately 11,854.22 billion yuan, an increase of about 1,754.72 billion yuan compared to the previous trading day [1] Stock Movement - Out of 4,472 stocks in the market, 4,472 stocks rose while 831 stocks fell, with 120 stocks hitting the daily limit up and 15 stocks hitting the daily limit down [1] Sector Performance - Leading sectors with notable gains included EDA, cross-border payment, unmanned vehicles, digital currency, financial technology, computer, biopharmaceuticals, chemical pharmaceuticals, complete automobiles, and electronic chemicals [1] - Sectors that experienced declines included gold, sugar substitutes/sweeteners, seasonings, leisure foods, precious metals, beauty care, food and beverages, and banking [1]

保险 队 中国人保 中国太保 中国平安 ■《》 3586.57亿市值 3334.41亿市值 9746.12亿市值 18.68亿成交额 5.80亿成交额 11.73亿成交额 53.52 8.11 34.66 +0.46(+1.35%) +0.23(+0.43%) -0.10(-1.22%) 酸酒行业 贵州茅台 五粮液 山西汾酒 19345.45亿市值 2290.85亿市值 4942.06亿市值 10.48亿成交额 20.36亿成交额 33.75亿成交额 1540.00 187.78 127.32 -0.22(-0.12%) +0.40(+0.32%) +3.00(+0.20%) 半导体 北方华创 寒武纪-U 2271.53亿市值 2558.59亿市值 15.27亿成交额 26.75亿成交额 425.24 612.90 +7.90(+1.89%) +2.91(+0.48%) 汽车整车 铁路公路 比亚迪 长城汽车 京沪高铁 2897.28亿市值 10974.98亿市值 1959.28亿市值 69.43亿成交额 3.62亿成交额 3.67亿成交额 5.90 22.89 361.13 -1.75(-0.48%) -0. ...

Core Points - The company announced a cash dividend distribution of 0.1 yuan per share for the fiscal year 2024, totaling approximately 161.56 million yuan [2][4] - The dividend distribution plan was approved at the company's annual general meeting on May 20, 2025 [2][6] - The cash dividends will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [3] Dividend Distribution Details - The total share capital before the distribution is 1,615,634,969 shares, with a cash dividend of 0.1 yuan per share [4] - Shareholders who have completed designated trading can receive their cash dividends on the distribution date at their designated securities firms [5] - For shareholders holding unrestricted circulating shares, the cash dividend will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [5] Taxation Information - For individual shareholders holding unrestricted circulating shares for more than one year, the cash dividend is exempt from personal income tax, resulting in an actual distribution of 0.1 yuan per share [8] - For shares held for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated based on the holding period when the shares are sold [8] - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.09 yuan per share [10] Convertible Bond Adjustment - The company announced an adjustment to the conversion price of its convertible bonds, "Jianyou Convertible Bonds," effective June 5, 2025, changing from 24.44 yuan to 24.34 yuan per share [14][16] - The adjustment is based on the company's 2024 annual profit distribution plan, which includes a cash dividend distribution [15][16] - The conversion of the bonds will be suspended from May 28 to June 4, 2025, and will resume on June 5, 2025 [16]

Group 1: Guangdong Private Enterprises Trade - In the first four months of this year, the import and export value of private enterprises in Guangdong reached 1.89 trillion yuan, a year-on-year increase of 5.6%, accounting for 63.9% of the province's total import and export value during the same period [1] Group 2: Hong Kong Tax Legislation - The Hong Kong Legislative Council passed the "2024 Taxation (Amendment) (Minimum Tax for Multinational Enterprises) Bill," which will implement a minimum tax rate of 15% for multinational enterprises with an effective tax rate below this threshold, expected to generate approximately 15 billion HKD in additional revenue annually starting from the 2027-2028 fiscal year [2][3] Group 3: Shenzhen Education Sector - The booking volume for "Gaokao rooms" in Shenzhen has increased by over 180% compared to the same period in 2023, placing it among the top ten cities nationwide for such bookings, reflecting heightened societal attention on the college entrance examination [4] Group 4: Foshan's City Ranking - Foshan has re-entered the "New First-tier Cities" list after two years, indicating significant improvements in urban strength, industrial development, and economic vitality, as well as its competitive position in the regional development landscape [5] Group 5: Shenzhen Stock Market Performance - The Shenzhen Component Index closed at 10,003.27 points, down 0.26% [6] Group 6: Stock Performance Highlights - Notable gainers in the Shenzhen market included Shuiyang Co., Ltd. with a 20.01% increase, and Huanlejia also up by 20.01%, while Anke Detection saw a decline of 12.97% [7]